I-iiMedia Ranking · 2025 China Innovative Drugs Global Expansion Leadership Ranking yethulwe ngokukhazimulayo eSingapore. Njengomshicileli kanye nomlingani wezinhloso ezithile, iStellar Biotech yasebenzisa inethiwekhi yayo yezinsizakalo ezisezingeni eliphezulu ezisetshenziswa kakhulu eNingizimu-mpumalanga Asia ukusiza izinkampani ezithuthukisa imithi ezintsha ezivela eChina ukuba zizakhele isikhundla esiqinile eSingapore futhi zakhe isikhungo sezidakamizwa esifundeni. Lolu hlu luhlanganisa "iqembu likazwelonke" lemithi emisha yaseChina okubalwa kuyo i-3SBio, i-Innovent Biologics, neSinopharm Group, lugcizelela inani le-Singapore njengesango eliyinhloko lemithi emisha yaseChina eya emhlabeni wonke futhi luvula isahluko esisha ekubambisaneni kwezimboni zemithi phakathi kweChina neSingapore.
Isikhundla Esisemthethweni Siyethulwa Edolobheni Lezingwe, Sakha Indawo Yokuhlasela Yamaphilisi Ase-China Ase-China Aye Emazweni Angaphandle
Isikhundla sokuqala sobuchwepheshe emhlabeni esigxile ekwandisweni kwemithi emisha emhlabeni wonke — iiMedia Ranking · 2025 China Innovative Drugs Global Expansion Leadership Ranking — sikhishwe ngokusemthethweni eSingapore ngoNovemba 17, 2025. Njengohlelo lokuhlola olunamandla ngaphansi kwe-iiMedia Research, lesi sikhundla sisekelwa uhlelo oluzenzakalelayo lwe-CMDAS olusekelwe kudatha enkulu futhi lunemodeli yokuqala yokuhlola enezinhlangothi ezine: Izingqinamba Zobuchwepheshe + Inqubekela Phambili Yomhlaba Wonke + Amandla Okuthengisa + Amandla Okusebenza Esifundeni. Kusukela ezinkampanini zemithi zaseShayina ezicishe zibe yi-4,000, sikhethe ngokunembayo Izinkampani Ezihamba Phambili ezingama-Top 40, okubandakanya: WuXi AppTec, BeiGene, CSPC Pharmaceutical, Sinopharm Group, Kelun Pharmaceutical, Shanghai Pharmaceuticals, Baili Tianheng, 3SBio, Ascentage Pharma, United Laboratories, Hengrui Medicine, Fosun Pharma, Huadong Medicine, Sinovac Biotech, Legend Biotech, Hansoh Pharma, Healthcare, Yifan Pharmaceutical, Innovent Biologics, Akeso Biologics, Junshi Biosciences, Zai Lab, Gan & Lee Pharmaceuticals, Rongchang Biologics, GenSci, Porton Pharma, YingEn Biologics, Everest Medicines, Hutchison MediPharma, Simcere Pharmaceutical, Deqiao Therapeutics, Aosaikang, Lepu Biologics, Jacobi Therapeutics, I-Mab, Dizal Pharma, 3D Medicines, Harbour BioMed, Lavel Biotech, PuraPharm Biologics.
Kusukela ngoNovemba 18, 2025, inani eliphelele lokuthengiselana ngamalayisense amaphilisi ase-China ase-China lidlule i-USD 103.43 billion, okumele kube ukwanda okungu-90.51% unyaka nonyaka kusuka ku-USD 54.29 billion unyaka ogcwele ka-2024. Cishe u-80% wale volumu yokuthengiselana ivela ezinkampanini ezisesikhundleni.
2025 China Innovative Drugs Global Expansion Leading Enterprises (Uhlu Lwengxenye)
Ukuqala kwe-iiMedia Ranking eSingapore kugcizelela indima yedolobha-lizwe njengesikhungo esiyinhloko sezidakamizwa eNingizimu-mpumalanga ye-Asia, okubaluleke kakhulu ngamasu. Le nkundla ibeka iSingapore njengesikhungo samasu esixhumanisa imithi yaseShayina enobuchule nezimakethe zomhlaba wonke, iqinisa umthelela we-Asia-Pacific endaweni yezidakamizwa zomhlaba wonke, ihambisa izinsiza zaseShayina ezisezingeni eliphezulu ezimbonini zezidakamizwa zaseSingapore, futhi ikhuthaza ukuhamba kobuchwepheshe nemali ngemikhawulo emibili. Ngaleso sikhathi, ngokusebenzisa iSingapore njengendawo "yokuqalisa", izinkampani zezidakamizwa zaseShayina ezinobuchule zingandisa ngokushesha emazweni ayi-10 aseNingizimu-mpumalanga ye-Asia, i-Australia kanye neNew Zealand, zakha ukuhlelwa okugcwele kwe-R&D — Ukubhaliswa — Ukuthengiswa.
I-Stellar Biotech: Umkhombisi Wezidakamizwa ZaseShayina Ezintsha Ezifikayo E-Southeast Asia
Njengomlingani wezinguquko ezikhethekile zokubalwa, i-Stellar Biotech ihlinzeka ngezinsizakalo eziyisinyathelo esisodwa kusukela ekubhalisweni kwezimiso kuya ekuthengisweni kwezinkampani ezifakwe ohlwini, kusekelwa inethiwekhi yayo enamandla "yezindawo ezimbili ezinkulu + ukumbozwa kwesifunda sonke" kanye nolwazi olubanzi lokubhalisa kwamanye amazwe. Izinsizakalo zayo eziyinhloko zihlanganisa izixhumanisi ezibalulekile ezifaka izicelo zokubhalisa zesifunda, ukwakhiwa kwenethiwekhi yokusabalalisa yendawo, kanye nokusekelwa kwezinto zokuthutha ezibandayo ezingaphezu kwemingcele, kuxazulula ngempumelelo izinselele zendawo ezinkampanini zemithi yaseShayina ezihamba emhlabeni jikelele.
Leli modeli lokunika amandla liletha inani elibonakalayo eSingapore: Ukungena kwezinkampani ezintsha zaseShayina ezithuthukisa imithi kubangela ukukhula kwamabhizinisi ahlobene nemithi futhi kudala imisebenzi edinga amakhono aphezulu; ukuqaliswa kwephrojekthi nokusebenza emakethe kunomthelela ngqo kumali engenayo yentela, kugcwalisa umfutho omusha emnothweni waseSingapore. Okubaluleke kakhulu, njengomkhuba omusha wemodeli "yokuhlelwa kobuchwepheshe + ukunikezwa amandla emakethe", iStellar Biotech, njengomvumela oyinhloko, iguqula "inani lokuhlola" lokuhlelwa libe "inani lokuqaliswa". Ngokuhlanganyela ukuhlela imihlangano yaseNingizimu-mpumalanga Asia yokuhambisana, imihlangano yokufanisa uhulumeni nezinkampani, kanye nezingqungquthela zokufanisa izinsiza zokwelapha, iStellar Biotech isiza izinkampani ezisohlwini ukuthi ziqonde ngokushesha imithetho yezimakethe zesifunda. Le modeli yokubambisana yandisa umthelela wezimboni wokuhlelwa ngeziyalo zeStellar Biotech ezisekelwe emhlabeni, yongeza ukukhulisa idumela laseSingapore njengesikhungo sezinsizakalo zemithi.
Inkulumo kaMnu. Lin, Usihlalo we-Stellar Biotech
UMnu. Lin, Usihlalo we-Stellar Biotech, uthe: “Sizibophezele ekwakheni iSingapore ibe yindawo ekhethwayo yezidakamizwa zaseShayina ezintsha ezihamba emhlabeni wonke. Ngokusebenzisa inethiwekhi yezinsizakalo ezitholakala endaweni ye-Stellar Biotech, izinkampani zemithi zaseShayina zingafinyelela imodeli yokwanda esebenza kahle ethi ‘Kubhaliswe eSingapore, Kuthengiswe kulo lonke i-Southeast Asia’, kunciphisa kakhulu umkhawulo wokuba ngamazwe omhlaba.”
Singapore: I-Springboard Egolile Yamaphilisi Ase-China Ase-China Ayisungulayo Aye Emazweni Angaphandle
Ngokuba nezinzuzo ezinhlanu eziyinhloko, i-Singapore isibe yindawo yamasu ekhethwayo yamaphilisi ase-China ase-China ukuba asakazwe eNingizimu-mpumalanga ye-Asia:
- Uhlelo lokulawula olwamukelwe ngamazwe omhlaba
- Inhliziyo ye-ASEAN Free Trade Area
- Iqoqo lezimboni zamaphilisi
- Isisebenzi esiphezulu samakhono
- Indawo yebhizinisi evuthiwe
Ngokukhishwa kwe-iiMedia Ranking · 2025 China Innovative Drugs Global Expansion Leadership Ranking kanye nokusekelwa kochwepheshe kwe-Stellar Biotech, imithi yaseShayina enezinto ezintsha yenza ngokushesha ukungena emakethe enkulu yaseNingizimu-mpumalanga ye-Asia. Le modeli yokubambisana kwezindawo eziningi ayisethi nje iSingapore njengendawo yokudlulisela imithi yaseShayina enezinto ezintsha, kodwa futhi ikhuthaza imvelo yezemithi ehlanganisa izinsiza ezintsha eziningi, izinsizakalo eziphelele zezimboni, nokufinyelela okubanzi emakethe. Njengoba izinkampani eziningi zemithi ezintsha zaseShayina ezihamba phambili zifika eSingapore nge-Stellar Biotech, iSingapore izoqhubeka nokudonsela izinsiza zochungechunge lwezimboni zemithi kulo lonke elase-Asia, iqinise isikhundla sayo esibalulekile njengendawo yokucwaninga, ukusabalalisa, kanye nezokuthutha imithi eNingizimu-mpumalanga ye-Asia, futhi ingeze umfutho oqhubekayo ekuthuthukisweni kwesikhathi eside kwesizwe.
Kukhishwe ngoNovemba 28, 2025
Skena ukuze ulandele